The changing face of methicillin-resistant Staphylococcus aureus infections

Alistair T Leanord and John Coia
Med J Aust 2017; 207 (9): . || doi: 10.5694/mja17.00641
Published online: 6 November 2017

Further success in controlling MRSA will require adapting our tactics to its shifting epidemiology

There is an ongoing global endeavour to reduce the incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections in health care settings. The major specific focus has been reducing MRSA transmission in hospitals, applying a combination of admission screening, isolation, and decolonisation, an approach allied to standard infection control precautions.1 In several countries this has significantly reduced the rate of serious MRSA infections, defined as the proportion of S. aureus bacteraemias that are methicillin-resistant; the United Kingdom, for example, has experienced an almost 90% reduction in MRSA bacteraemias over ten years.2 Similarly large reductions in MRSA rates have been reported in Australia.3,4

  • 1 NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom
  • 2 Scottish Microbiology Reference Laboratories, Glasgow, Scotland, United Kingdom

Competing interests:

No relevant disclosures.

  • 1. Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63S: S1-S44.
  • 2. NHS Scotland. Chief Executive’s annual report 2015/2016. Edinburgh: The Scottish Government, 2016. (accessed Sept 2017).
  • 3. Mitchell BG, Collignon PJ, McCann R, et al. A major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia — 12 years of progress: an observational study. Clin Infect Dis 2014; 59: 969-975.
  • 4. Worth LJ, Spelman T, Bull AI, et al. Staphylococcus aureus blood stream infection in Australian hospitals: findings from a Victorian surveillance. Med J Aust 2014; 200: 282-284. <MJA full text>
  • 5. Umscheid CA, Mitchell MD, Doshi JA, et al. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32: 101-114.
  • 6. Park SY, Chung DR, Yoo JR, et al. Sequence type 72 community associated meticillin-resistant Staphylococcus aureus emerged as a predominant clone of nasal colonization in newly admitted patients. J Hosp Infect 2016; 93: 386-389.
  • 7. Potel C, Rey S, Otero S, et al. Molecular characterization and clonal diversity of meticillin-resistant Staphylococcus aureus isolated from the community in Spain: emergence of clone sequence type 72. J Hosp Infect 2016; 93: 382-385.
  • 8. Donker T, Bosch T, Ypma RJF, et al. Monitoring the spread of meticillin-resistant Staphylococcus aureus in the Netherlands. J Hosp Infect 2016; 93: 366-374.
  • 9. Smith TC. Livestock-associated Staphylococcus aureus: the United States experience. PLoS Pathog 2015; 11: e1004564.
  • 10. van Cleef BAGL, Monnet DL, Voss A, et al. Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis 2011; 17: 502-505.
  • 11. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23: 616-687.
  • 12. Agostino JW, Ferguson JK, Eastwood K, Kirk MD. The increasing importance of community-acquired methicillin-resistant Staphylococcus aureus infections. Med J Aust 2017; 207: 388-393.
  • 13. Health Protection Scotland, National Services Scotland. The value of nasal swabbing versus full body screening or clinical risk assessment to detect MRSA colonisation at admission to hospital. Glasgow: Health Protection Scotland/National Services Scotland, 2011. (accessed Sept 2017).
  • 14. Huijsdens XW, van Dijke BJ, Spalburg E, et al. Community-acquired MRSA and pig-farming. Ann Clin Microbiol Antimicrob 2006; 5: 26.
  • 15. Price JR, Golubchik T, Cole K, et al. Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2014; 58: 609-618.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.